INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 13 filers reported holding INNATE PHARMA S A in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,000 | – | 1,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 4,545,454 | $29,273,000 | 2.64% |
| Rubric Capital Management LP | 1,350,000 | $8,694,000 | 0.98% |
| Maven Securities LTD | 130,000 | $836,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 44,226 | $284,000 | 0.01% |
| OLD MISSION CAPITAL LLC | 13,038 | $84,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200,000 | $1,288,000 | 0.00% |
| FNY Investment Advisers, LLC | 1,795 | $11,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,353,773 | $8,705,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 74,242 | $477,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |